Welcome

  • Moulder Center and Temple School of Pharmacy's Launch Start-up Biotech Praeventix LLC Focused on IBD Therapies

    Philadelphia, PA February 2, 2017 - A startup emerging from Temple University's School of Pharmacy builds on the work of two of its medicinal chemists and could potentially change the way inflammatory bowel disease is treated.  The company, Praeventix, is advancing a discovery made by the School of Pharmacy’s Daniel Canney and Benjamin Blass of the Moulder Center for Drug Discovery Research.

  • Temple spinoff Express Cells secures first patent for gene-editing technology

    A three-year-old Philadelphia genetic engineering company spun out of Temple University has secured its first patent for its core gene-editing technology.

  • The Temple University School of Pharmacy Establishes the Magid Abou-Gharbia Endowed Fund to Support Medicinal Chemistry

    Philadelphia, PA – March 8th, 2021.  The Temple University School of Pharmacy has launched a fundraising campaign in honor of Magid Abou-Gharbia, PhD, FRSC to support medicinal chemistry. We invite all members of our communities to donate in tribute to Dr. Abou-Gharbia. To contribute, click to donate to the Magid Abou-Gharbia Endowed Fund online now or contact Christopher Van Vessem, Assistant Dean for Development & Alumni Relations, at cvv110@temple.edu.

  • Moulder Center for Drug Discovery Research endowed with $5 million pledge

    Temple University School of Pharmacy alumni Lonnie and Sharon Moulder are continuing their commitment to the Moulder Center by pledging $5 million to endow the center

  • TUSP Research Receives National and International Media Coverage

    Dr. Salim Merali led a team of researchers who have shown that binge eating may lead to type 2 diabetes.

  • Basic Principles of Drug Discovery and Development 2nd edition Published by Dr. Benjamin E Blass

    The second edition of Basic Principles of Drug Discovery and Development, a textbook written by Dr. Benjamin E Blass and published by Academic Press, was released today. This newly updated textbook presents the multifaceted process of identifying a new drug in the modern era, providing comprehensive explanations of enabling technologies such as high throughput screening, structure based drug design, molecular modeling, pharmaceutical profiling, antibody therapeutics, genomics, proteomics, and translational medicine, all areas that have become critical steps in the successful development of marketable therapeutics.

The Moulder Center for Drug Discovery Research was dedicated on May 14, 2009 and is currently home to a talented and enthusiastic group of scientists. The team is dedicated to facilitating collaborative research efforts to support the discovery and development of novel therapeutic agents to improve the health and life of patients. The Moulder Center serves as a multidisciplinary research hub for the further development of scientific discoveries identified by Temple University faculty and scientists, enabling their research to move beyond the lab and into the broader research community. In addition, the Moulder Center’s unique capabilities and experienced scientists actively pursue collaborative research opportunities with external collaborators in the academic community and industrial partners both in the U.S. and abroad.

 

Temple University
Moulder Center for Drug Discovery Research

Temple University School of Pharmacy
3307 N Broad Street
Philadelphia, PA 19140